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A review of mammographic positioning image quality criteria for the craniocaudal 
projection. 
 
 
Short Title: 
Review mammographic positioning image quality criteria: CC projection 
 
  
  
Abstract 
Detection of breast cancer is reliant on optimal breast positioning and the production of 
quality images. Two projections, the mediolateral (MLO) and craniocaudal (CC), are 
routinely performed. Determination of successful positioning and inclusion of all breast 
tissue is achieved through meeting stated image quality criteria. For the CC view, current 
image quality criteria are inconsistent. Absence of reliable anatomical markers, other than 
the nipple, further contribute to difficulties in assessing the quality of CC views. 
 
The aim of this paper was to explore published international quality standards to identify and 
find the origin of any CC positioning criteria which might provide for quantitative 
assessment. The pectoralis major (pectoral) muscle was identified as a key posterior 
anatomical structure to establish optimum breast tissue inclusion on mammographic 
projections. It forms the first two of the three main CC metrics that are frequently reported 1. 
visualisation of the pectoral muscle, 2. measurement of the posterior nipple line (PNL) and 
3. depiction of retroglandular fat.  
 
This literature review explores the origin of the three metrics, and discusses three key 
publications, spanning 1992 to 1994, on which subsequent image quality standards have 
been based. The evidence base to support published CC metrics is sometimes not specified 
and more often the same set of publications are cited, most often without critical evaluation.  
 
To conclude, there remains uncertainty if the metrics explored for the CC view support 
objective evaluation and reproducibility to confirm optimal breast positioning and quality 
images. 
 
 Introduction 
Mammography is radiographic imaging of the breast. It is undertaken with presenting signs 
and symptoms of breast disease and on asymptomatic women through population based 
breast cancer screening programmes. In both settings, although the prevalence of disease 
may differ, the emphasis is on detection of breast cancer although a range of breast 
pathologies may be demonstrated. 
 
The goal of breast screening programmes is the early detection of breast cancer, with 
programme effectiveness primarily measured in reduction of breast cancer mortality rates. 1 
To detect breast cancer at its earliest stage, the screening service must achieve optimum 
image quality at the lowest possible risk from the radiation dose. 2-4  Quality Assurance 
(QA) programmes are essential to ensure compliance with the guidelines, image quality 
standards, protocols, and criteria that guide breast screening and diagnostic mammographic 
services. 5, 6 The adequacy of image quality standards can be inferred from the sensitivity 
and specificity of imaging. 
 
Published national and international quality standards continue to provide differences in 
described image quality criteria and impact upon clinical image assessment comparisons and 
effective research into mammography. 7, 8 An example is the inclusion of a classification 
system by which image quality can be visually assessed and evaluated. One of the most 
reported is a system where images are ranked as perfect, good, moderate or inadequate 
(PGMI). 9, 10 Whilst there had appeared to be greater conformity for the MLO criteria 
reported, 11, 12 a recent study by Taylor et al has proposed a new scoring system of perfect, 
good, adequate or inadequate with new positioning quantitative metrics added for the MLO 
 view. 13 In the meantime, ambiguity and differences in description and expectations from 
specific criteria for the CC view continue.  
 
QA goals need to be continually reassessed to ensure they reflect changing technology,14 
evidence base and the “skills of breast positioning, compression, and technique selection”. 15 
p.807 The focus of this review is image quality control (QC) criteria to assess CC breast 
positioning accuracy which is integral in ensuring that all breast tissue is included. 
 
Background 
The CC projection 
Before we consider the importance of image quality criteria for the CC projection, it is 
necessary to examine the importance of the CC projection itself. Two view mammography 
combining the MLO and the CC projections creates a three dimensional representation of the 
breast. Two view mammography is described for both initial and incident (or subsequent) 
screening rounds by the UK BreastScreening Programme, American College of Radiology, 
BreastScreen Australia and BreastScreen Aotearoa. 6, 16-19 
 
The inclusion of the CC projection aims to increase early detection of breast cancer, increase 
sensitivity and reduce the incidence of interval cancers. Two views allow for visualisation of 
breast pathologies which manifest in a single view, either the MLO or CC, as a ‘one-view’ 
finding of an abnormality and require further evaluation. 20-22 Similarly, mammographic 
features that appear benign in one projection may appear differently and more suspicious on 
the other. 23 Breast tissue missed on one projection should be included on the other, 
 otherwise repeat positioning or supplementary projections may be required adding to the 
radiation burden of the examination. 
 
Mammographic positioning and equipment  
For clarity and conciseness, in this article we have used the generic term ‘radiographer’ to 
apply to the health professional responsible for conducting the mammographic examination. 
Incorrect positioning by radiographers can result in poor quality images due to inadequate 
demonstration of breast tissue, insufficient compression, and presence of artefacts. All of 
these factors will impact diagnosis 24 and can contribute to missed breast cancers. 21, 25-31 
 
During positioning for mammography there are minimal anatomical landmarks for reference 
to confirm all breast tissue has been included. General radiographic positioning is provided 
by landmarks, usually skeletal or skin surface anatomy, to confirm the area of interest will be 
included. The nipple is the anterior reference point for both MLO and CC projections.32 
Positioning is aimed at demonstrating the pectoral muscle to provide a key image quality 
criterion to confirm inclusion of posterior breast tissue. 17, 19, 33 There is a lack of anatomical 
landmarks to determine inclusion of medial and lateral breast tissue. Nevertheless during 
positioning, in order to include medial tissue on the CC, lateral tissue may be missed 34-36.  
 
A further positioning consideration is the placement of the image receptor (IR) in relation to 
the inframammary fold (IMF) of the breast.37 As early as 1992 Eklund and Cardenosa 38 
described elevating the IMF during CC positioning “to the limit of its natural ability” (p.35) as 
a contributor to including more upper posterior breast tissue, with Bassett et al. 36 
confirming this positioning method. This recommendation is recently described as lacking in 
consensus in the literature leading to research into the amount of breast tissue, described as 
 the ‘breast footprint’, 39 actually included on the (IR). The configuration of the size and 
depth of current IR platforms may be contributing to the ease, or difficulty, in achieving 
adequate positioning of the breast. 2, 40, 41 Training in positioning techniques specifically 
suited to full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) 
has been reported as a contributor to better inclusion of breast tissue. 42 
 
Compression paddle design has evolved since the early 1990’s and can also influence breast 
tissue inclusion on the CC. A biphasic (angled) paddle resulted in increased incidence of 
pectoral muscle inclusion, although there was less impact on the PNL. 43 Comparison of 
flexible and rigid designs demonstrated inclusion of pectoral muscle more consistently, but 
tended to push fibroglandular tissue off the image posteriorly. 44 
 
Given patient and equipment variables, it is not surprising that positioning continues to be 
seen as a challenge to quality of mammographic practise 45 and has been included as reason 
for failure to adhere to mammography accreditation and quality standards. 46-52 Indeed the 
American Food & Drug Administration reported that in 2015 during the first attempt at ACR 
accreditation, of all clinical images found to be deficient 92% were due to deficiencies in 
positioning, a compelling and concerning finding. 50 
 
Literature review 
Review Method 
Despite published research for the MLO image quality criteria which appears to be widely 
accepted, 12, 53-55 the literature for positioning in general continues to challenge the validity 
and ability to confirm and quantify positioning criteria. 12, 13, 54, 56 A paucity of validated 
 evidence for the CC criteria remains, 42, 57, 58 even with the stated importance of the 
projection. The method of this review has therefore been to establish the origin of image 
quality criteria pertaining to inclusion of posterior breast tissue on the CC. For this review 
‘image quality standards’ is used to identify quality assurance (QA) guidelines and protocols 
specific to mammographic imaging. ‘Image quality criteria’ is used to describe quality 
control (QC) of mammographic projections.  
 
Current mammographic image quality standards were reviewed first to establish common 
descriptors of CC positioning criteria used to determine optimal inclusion of posterior breast 
tissue (see Table 1). Three criteria emerge which reference the pectoral muscle, these are the 
posterior nipple line (PNL), the ‘1 cm rule’, and retroglandular fat.   
 
To establish the origins of the three criteria identified, a literature search in OvidSP 
(Medline) and Scopus was conducted by the first author. Attention was given to word 
inclusion of, but not limited to, mammog*, position*, image quality, nipple line, pec* 
muscle, retroglandular, craniocaudal (CC), mediolateral oblique (MLO), projection, 
compression, breast screen.  
 
No limitation was placed on publication year and is current to October 2017. Given the 
historical context of the literature reviewed, a comprehensive search was achieved through 
further review of in-text citations, references, and bibliographies. Due to the emergent nature 
of positioning criteria disparity all articles were considered if they included reference to the 
CC projection. Mammographic image quality standards emerging from as early as 1989 59-61 
62 were also reviewed but most often had a restricted reference list.  
 
  
Origins of CC criteria 
Three source articles by Eklund and Cardenosa (1992), Bassett, Hirbawi, DeBruhl, and 
Hayes (1993), and Eklund, Cardenosa, and Parsons (1994) were identified as the first to 
explain the CC criteria. 36, 38, 63 Further analysis of the three key articles provided a metric 
for the percentage of CC images which should include pectoral muscle. A summary of key 
image quality criteria descriptors for the CC projection includes additional contributing 
literature (see Table 1). Literature relating to earlier mammographic examination techniques, 
and initial mammographic quality control guidelines published by the ACR (1992) 59 and for 
the UKNHSBSP (1989), 64 were also considered but no evidence was identified for the three 
criteria, nor any alternative discussed.  
 
Variability in attaining correct positioning of the breast and production of good quality 
images is well recognised in the literature.  11, 13, 42, 57, 58 In spite of this, of the three key 
articles identified for this review, only the U.S. 1993 study by Bassett et al. describes a study 
method and materials to test image quality criteria for positioning from which subsequent 
recommendations were provided. This prospective study comprised 1,000 consecutive 
bilateral screening mammograms (2,000 CC and 2,000 MLO images) 36 completed by six 
radiographers experienced in mammography who had completed training to reflect what 
were then ‘new’ methods of positioning. Both positioning methods and evaluation criteria 
were clearly stated for both projections by which the mammograms would be evaluated; for 
the CC projection three positioning descriptors and six evaluation criteria. The radiographers 
assessed the quality of their images and repeated any they considered unacceptable. The 
repeat rate was reported as “consistently below 5%” and it has to be assumed that all 
 reported data arose from images that excluded those repeats. The validity of the results is 
therefore somewhat reduced. 
 
Inclusion of the pectoral muscle on the CC was stated at 32% (inter-radiographer variability 
22% - 60%). When available, mammograms were compared to previous mammograms from 
within a two year period (59% of cases). Individual radiographer positioning for the same 
patient was not, however, compared. 36 79% of the CC views were stated as achieving a 
PNL measurement “within 1 cm greater or less than the depth on the MLO”, albeit an 
ambiguous description. Given the current application of the ‘1 cm rule’ it should be noted 
that 54% of the CC views assessed within this study were actually within 0.5cm of the MLO 
measurement. For the MLO 90% demonstrated a depth of tissue that was greater or equal to 
that depicted on the CC images (inter-technologist variability 88% - 94%). A greater ability 
to position the breast in the MLO position tends therefore to be confirmed. Within the 
context of this study the PNL is described to the pectoral muscle or edge of film whichever 
comes first, thus leaving some ambiguity to the overall effectiveness of such metrics and the 
study outcomes to be considered cautiously. 36 
 
It is of interest that evaluation of the PNL and use of the ‘1 cm rule’ by Bassett et al. (1993) 
36 was attributed to Eklund and Cardenosa (1992) 38 although their article does not in fact 
refer to those metrics. By 1994,  Eklund et al. 63 did include the PNL with the finding that of 
300 consecutive mammogram examinations reviewed the MLO PNL averaged 0.62cm 
greater (range not reported) than that on the CC. Subsequently the authors recommended the 
MLO PNL to be not greater than 1cm of the CC measurement. Research methodology for 
the 1993 study and the 1994 review is not evident but clearly stated rationale for establishing 
positioning and evaluation guidelines is provided. It is considered that concurrent studies 
 during that time might attribute to such cross-over of recommendations, but was not 
reflected chronologically by the publication dates (see Table 3).  
 
Limitations of CC criteria  
Two of the three identified CC criteria can be considered problematic as they do not offer 
metrics that are consistently achievable. When considering the first non-metric criterion, 
retroglandular fat is not likely to be identified in a breast that is mostly fatty replaced, nor 
where there is scattered or only moderate amounts of fibroglandular breast tissue. 63, 65, 66 
The retroglandular fat criterion is also of limited value when glandular tissue overlies the 
pectoral muscle or extends to the edge of the image. Inclusion of the pectoral muscle, the 
second non-metric criterion, is not consistently achieved. 36, 58, 67 
 
The PNL measurement is the only quantitative criterion available to assess the adequacy of 
the CC image, and is applied in conjunction with a ‘1 cm rule’. When compared between the 
same side MLO and CC projections, the PNL should be within, or less than, 1 cm of each 
other. Although described with some frequency within the literature it is not evident in all 
image quality standards, (see Table 1). There is also a wide range of descriptors for the 
“nipple line” or “posterior nipple line”, 12 and “nipple axis line”. 68 Variations include 
orientation on the MLO, nipple or nipple-skin interface, and posteriorly to the muscle or to 
the back of the image (see Table 2; Figure 1). 
 
The PNL and ‘1 cm rule’ metrics do provide for comparison of depth of breast tissue and can 
be used regardless of inclusion of the pectoral muscle on the CC (see Figure 2). Yet in the 
absence of pectoral muscle to nipple level on the MLO, which can be an uncertainty and 
common fault, 11, 63, the 1 cm measurement will be to the back of the image for both views 
 (see Figure 3). This then has limited value on its own as posterior breast tissue inclusion is 
not confirmed despite the PNL metric being met. It has also been documented that breast 
tissue visualised on CC views can exceed that of the MLO, which might question adequacy 
of the MLO positioning. 36 
 
Even though a PNL measurement for a CC remains within 1 cm of the MLO, suggesting 
satisfactory positioning, it may not confirm that the breast is pulled as far forward during 
positioning as is possible, 69  nor might it confirm visualisation of fibroglandular tissue that 
extends posteriorly. 20 If the nipple is not in profile on both MLO and CC then the PNL 
measurement is also compromised as the anterior anatomical landmark may not be easily 
identified. 
 
Discussion 
Differences in CC criteria is exemplified by BreastScreen Aotearoa (New Zealand) (2106) 
requirement for inclusion of the pectoral muscle as part of an “excellent” (in place of 
perfect) CC image whilst there is no reference to the ‘1 cm rule’. 19 BreastScreen Australia 
(2015) requires the “PNL to be within 1 cm of PNL on MLO view” for a “perfect” CC 
image. Inclusion of pectoral muscle for this classification is implied diagrammatically but 
not explicitly stated. In the UK although the PGMI system, or equivalent, is often used for 
training and ongoing quality improvement, at national level the 2006 UKNHBSP 33 image 
quality standards do not specifically refer to the PGMI rankings. Criterion for inclusion of 
the pectoral muscle on the CC is stated  as “Pectoral muscle shadow may be shown on the 
posterior edge of the breast on some CC views depending on anatomical characteristics”. 17 
There is a further lack of conformity of criteria for inclusion of the medial and axillary tail of 
the breast (see Table 1).  
  
Inclusion of pectoral muscle 
The literature available to be reviewed often gave reference to what percentage of CC 
images should include pectoral muscle posteriorly (ranging from 20% - 60%). 36, 42, 58, 67 
Although the 1993 study provided a range of 22%-60%, 36 a 2011 audit of 200 pairs of CC 
and MLO projections used to assess achievement of the “≤ 1cm rule” found only 11% 
included pectoral muscle. 31.5% successfully met the ‘rule’ criterion. 58 A 2015 published 
review of image quality criteria for positioning comparing the imaging technique of newly 
trained and experienced radiographers in the Netherlands found concordance with 41% 
depiction of pectoral muscle for the CC projection. The range was not provided and there 
was no reference to use of the PNL or 1cm criteria. 67  
 
A high frequency of pectoral muscle inclusion on CC views has been suggested to indicate 
positioning which is biased towards the lateral aspect of the breast leading to loss of medial 
tissue, although this does not appear to be have been supported in the literature. 70 As with 
the MLO, where the posterior aspect of the breast is generally thicker than the anterior, 
adequate compression over the entire breast might also be compromised. 38, 71 Pectoral 
muscle inclusion is ranked as necessary for ‘perfect’ or ‘excellent’ images for some image 
quality classification systems, 17, 19 but not included in other image quality standards. The 
value of a stated percentage for successful inclusion of the pectoral muscle on the CC is 
questioned as a valid criterion for current use. There is a disparity of recommendations but 
early research from within the digital mammography environment may contribute to new 
discussion. 42 
 
‘1 cm rule’ 
 Percentage values for inclusion of the pectoral muscle and PNL with 1 cm metric criteria 
were originally described for practical use to guide improvement in positioning by Bassett at 
al. (1993). 36 The criteria were considered objective enough to evaluate mammographic 
practice. It was suggested that the 1 cm metric was the more consistent determinant of 
inclusion of posterior tissue. 36 However, as compression ‘spreads out’ tissue it is reasonable 
to expect a larger ‘footprint’ of breast tissue area on the IR, 37 confounding the application of 
the ‘1 cm rule’. This is likely to be more evident for the CC, given that posterior inclusion of 
pectoral muscle is expected to be greater on the MLO.  
 
Given that a greater volume of pectoral muscle can impact on compressibility of breast 
tissue, 38, 72 the ability of MLO compression to match the footprint for the CC projection 
may be reduced. With such discordance between MLO and CC subsequent spread of breast 
tissue, the ability to apply the ‘1 cm rule’ then compromises the ability to compare the 
‘amount’ of breast tissue included. Correspondingly, variability of breast size and shape does 
not seem to have been considered when applying a metric of length only. In the absence of 
such a consideration there is no indication of the volume of breast tissue that might be 
excluded from a mammogram.  
 
Medial and lateral tissue inclusion considerations 
A recently published study evaluated positioning for FFDM and DBT with comparison to 
the film-screen study of 1000 patients by Bassett and colleagues (1993). 42 Although a 
smaller study (170 patients), improved outcomes for inclusion of medial and lateral breast 
tissue on the CC view were reported. For the CC, visualisation of cleavage was used to 
confirm inclusion of medial breast tissue. This criterion was new so a direct comparison with 
the 1993 study was not possible. Comparison of ‘lateral glandular tissue’ was able to be 
 provided as a comparative positioning criterion. 42 As with the non-metric criterion of 
visualisation of retroglandular fat, it is difficult to quantify the presence of glandular tissue 
as a criterion as there is no associated anatomical marker, and varies both inter- and intra-
patient. When tissue more lateral to any glandular tissue is visualised then such glandular 
tissue cannot be determined as the most lateral breast tissue. 
 
Future Directions 
Digital Mammography 
Digital mammography offers new opportunities. Automated evaluation methods 73 could 
combine with current research, namely compression studies, assisting with better 
understanding of the area of breast included on the IR. Such methods could also record and 
report volumetric data for the amount of breast tissue imaged. A cautionary note is 
determination of sufficient anatomical landmarks on the CC view to provide reproducible 
results. Nonetheless automated evaluation methods could better inform both research 44 and 
validate image quality criteria for clinical application.  
 
Inconsistent application of known and ‘silent’ criteria  
Consistent with previous research, educational, training and auditing metrics have not 
necessarily matched national standards. 11, 57 Exploration of both radiographer and 
radiologist image quality assessment has attempted to rank the importance of positioning 
criteria, 13 whilst radiographer decision making during image acquisition remains unknown. 
This review has identified the inclusion of the cleavage as a CC criterion recently added to 
the body of literature. 42  Within clinical practice a further range of undocumented practice 
for evaluation of CC positioning and adequate inclusion of breast tissue is likely to be used. 
It is expected that exploration of this phase during mammographic imaging could determine 
 if there is consistent application and ranking of the identified criteria for the CC. There may 
be unidentified criteria ‘silent’ from the literature which are likely to be untested. Research 
would provide the opportunity for identification of such criteria and testing for their validity 
and inclusion in image quality standards if found effective. 
 
 
Conclusion 
To date, the evidence for the CC positioning image quality standards and criteria, and 
national guidelines remain unclear. The literature and publications are often inconsistent and 
subjectively clinical practice may not necessarily be reflecting best practice. 11, 12, 57, 58, 67, 74 
Differences in the criteria suggest varying image quality outcomes with the potential for 
cancer detection performance to be questioned. The call for a uniform and validated system 
prevails 10, 11, 13, 57 as this would support those in the education and practice of 
mammography.42, 75  
 
Regardless of any such future considerations, the impetus for this review has been to 
determine optimum positioning for the CC projection with renewed attention required to 
establish which of the three identified criteria might have merit to successfully confirm 
inclusion of posterior breast tissue. It would be expected that knowledge arising from such 
research will inform which of the CC image quality criteria or any others revealed has 
validity to provide a platform for change of mammographic practice during image quality 
criteria assessment and subsequent clinical decision making for repeat imaging when the 
pectoral muscle is not demonstrated. 
 
 Anatomical markers are limited to the nipple anteriorly and sometimes the pectoral muscle 
posteriorly. This impacts on the ability to provide quantitative and reproducible metrics for 
optimal positioning and evaluation of images. Nevertheless, it is unclear why variation exists 
in the image quality criteria and whether CC views are achieving the stated aim of imaging 
‘all breast tissue’, or perhaps more appropriately, ‘as much as possible’.  Despite limitations 
of suitable anatomical markers, objective criteria are needed for use during positioning, so 
that resultant images can be evaluated objectively and compared with previous 
mammographic examinations. It is recommended that the existing mammographic image 
quality guidelines for the CC projection be consolidated into an evidence-based framework 
that allows objective evaluation of image quality during mammography.  
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 Table 1 Descriptor summary for optimum craniocaudal (CC) positioning criteria 
 
NB:  Imaging of ‘all or maximum breast tissue’ with the ‘nipple in profile’ are recognised as 
frequently stated criteria and not repeated in this table. 
 
Image quality standards Positioning descriptor summary  
United Kingdom National Health 
Service Breast Screening 
Programme (UKNHSBSP), 2006 
33 
p.42-43
 
CC specific criteria:  
 medial border of the breast (according to local protocols) 
 some of the axillary tail of the breast 
 pectoral muscle shadow may be shown on the posterior edge of the 
breast on some CC views depending on anatomical characteristics 
European guidelines for quality 
assurance in breast cancer screening 
and diagnosis, 2006 
18 p.173
 
 
CC specific criteria:   
 medial border of the breast is shown 
 as much as possible of the lateral aspect of the breast is shown 
 if possible, the pectoral muscle shadow is shown on the posterior edge 
of the breast  
BreastScreen Aotearoa,  
New Zealand, 2016 
19 p.124-125
 
 
CC Excellent images: 
 medial aspect shown 
 as much axillary tail as possible 
 pectoral muscle shadow at chest wall 
CC Good and Moderate images: 
 as for Excellent category, except pectoral muscle not shown but breast 
tissue imaged well back to chest wall 
American College of Radiologists 
(ACR), 2017 
76
 
 
 Clinical assessment evaluates retromammary aspects of the breast 
between the craniocaudal (CC) and mediolateral oblique (MLO) 
views.  
 the CC PNL should be no more than 1 cm less (approximately) than 
that on the MLO view 
 
BreastScreen Australia, 2015 
17 
p.180-181
 
CC Perfect images: 
 medial border well demonstrated  
 posterior nipple line (PNL) within 1cm of PNL on MLO view 
  CC Good images: 
 all postero-medial tissue visualised (*axillary portion of breast not to 
be included at expense of medial portion)  
CC Moderate images: 
 most breast tissue imaged (however, all breast tissue must be imaged 
on MLO image) 
  
 Table 2   
Variations of descriptors for the posterior nipple line as applied to the craniocaudal (CC) 
view 
Source Descriptor of the posterior nipple line for the CC 
Bassett, Hirbawi, DeBruhl, and Hayes (1993) 
36 p.803-804
 
Directly posteriorly from nipple to pectoral muscle or edge of 
film, whichever comes first 
Eklund, Cardenosa, and Parsons (1994)  
63 p.300
 
Nipple-skin to back of image (regardless of pectoral muscle 
inclusion) 
American College of Radiology (2017) 
76
 Nipple to posterior edge of the image 
BreastScreen Australia (2015)
17 p.180
 Nipple to pectoral muscle  
 
 
  
 Table Three  
Summary of the origins for the three key image quality criteria descriptors for the 
craniocaudal (CC) view  
Author and Year 
Inclusion of Pectoral 
Muscle  
PNL and 1cm 
measurement 
Retroglandular 
fat 
Eklund and Cardenosa (1992) 
38, p.36
 * more than 25% nil nil 
Hendrick, Bassett and Dodd (1992) 
59, 9.75
 * approximately 20%  nil nil 
Bassett, Hirbawi, DeBruhl, and Hayes (1993) 
36, 
p.805
 
32%  Yes Yes 
Eklund, Cardenosa, and Parsons (1994) 
63, p.300
 * 30 – 40% Yes Yes 
Bassett, Hendrick and Bassford (1994) 
77, p.66
 * approximately 30%  Yes Yes 
European Commission (1996) 
78
 * Yes nil Yes 
American College of Radiology (1999) 
79, p.86
 * 30% to 40% Yes Yes 
 
* evidence base not cited  
 Figure Captions: 
 
Figure 1. Descriptors for the posterior nipple line 
o CC and MLO: posteriorly to pectoral muscle or back of image 
o MLO: there may be variations in the orientation of the PNL 
 
Figure 2. The PNL may be applied for the CC view regardless of inclusion of the pectoral 
muscle on the CC 
 
Figure 3. Assessment for the CC view requires more than one criterion to confirm 
positioning image quality. A PNL measurement to the ‘back of the image’ cannot confirm 
presence of posterior breast issue in the absence of pectoral muscle on both views. 
 
